IPR Decision on '371 a 'Double Whammy' for Shockwave Medical (SWAV) IP Claims - Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Suraj Kalia reiterated weighed in Shockwave Medical (NASDAQ: SWAV), saying the IPR decision on '371 case also a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
